Hui Tian

Partner at The Column Group

Dr. Hui Tian joined The Column Group in 2022 as a Venture Partner. Previously he was a founding member of NGM Biopharmaceuticals and most recently served as Senior Vice President of Research. In this role, he was responsible for discovery research across multiple therapeutic areas including metabolic diseases, retinal diseases and cancer. In a span of 14 years, he led the discovery and advancement of more than a dozen clinical candidates. Prior to NGM, he was a Scientific Director at Amgen and Tularik leading discovery research in the areas of metabolic disorders and orphan G protein-coupled receptors.

Dr. Tian received a Ph.D. in Molecular and Cellular Biology at the University of Texas Southwestern Medical Center and did his post-doctoral training at Harvard University.

Location

San Mateo, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


The Column Group

1 followers

The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early-stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics.


Industries

Employees

11-50

Links